Study of NM8074 in Adult PNH Patients With Inadequate Response to Soliris

NCT05646563 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Paroxysmal Nocturnal Hemoglobinuria

Interventions

DRUG: NM8074
DRUG: Soliris

Sponsor

NovelMed Therapeutics